Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Methicillin-Resistant Staphylococcus Aureus
96%
Cross Sectional Study
64%
Cross-Sectional Study
50%
Carbapenemase Producing Enterobacteriaceae
50%
Antibiotics
37%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
28%
Extended Spectrum Beta Lactamase
25%
Enterobacteriaceae
21%
Vancomycin-Resistant Enterococcus
21%
Carbapenemase
21%
Mixed Infection
8%
Antiinfective Agent
8%
Antibiotic-Resistant Bacteria
8%
Infection
8%
Respiratory Tract Infection
7%
Nursing and Health Professions
Emergency Ward
100%
Prevalence
100%
Extended Spectrum Beta Lactamase
53%
Cross-Sectional Study
50%
Methicillin-Resistant Staphylococcus Aureus
46%
Antibiotic Therapy
23%
Carbapenemase
21%
Vancomycin-Resistant Enterococcus
21%
High Risk Population
8%
Control Strategy
8%
Mixed Infection
8%
Antimicrobial Stewardship
8%
Infection Control
8%
Clinician
8%
Hospital
7%
Urinary Catheter
7%
Female Patient
7%
Hospitalization
7%
University Hospital
7%
Respiratory Tract Infection
7%
Immunology and Microbiology
Prevalence
100%
Methicillin-Resistant Staphylococcus Aureus
96%
Carbapenemase Producing Enterobacteriaceae
50%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
28%
Nose
21%
Rectum
21%
Enterobacteriaceae
21%
Vancomycin-Resistant Enterococcus
21%
Heterozygote
16%
Antibiotic-Resistant Bacteria
8%
High Risk Population
8%
Coinfection
8%
Clinical Microbiology
7%
